about
Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.The role of oxidative stress in Parkinson's diseaseCurcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st centurySolvents and Parkinson disease: a systematic review of toxicological and epidemiological evidenceStructure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's diseasealpha-Synuclein aggregates interfere with Parkin solubility and distribution: role in the pathogenesis of Parkinson diseaseOut FOXing Parkinson disease: where development meets neurodegeneration.Copy number variability in Parkinson's disease: assembling the puzzle through a systems biology approachAggresome-forming TTRAP mediates pro-apoptotic properties of Parkinson's disease-associated DJ-1 missense mutations.Positive reciprocal regulation of ubiquitin C-terminal hydrolase L1 and beta-catenin/TCF signalingStructure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disordersDefects in very long chain fatty acid synthesis enhance alpha-synuclein toxicity in a yeast model of Parkinson's disease.Expression by midbrain dopamine neurons of Sema3A and 3F receptors is associated with chemorepulsion in vitro but a mild in vivo phenotype.Parkinson's disease DJ-1 L166P alters rRNA biogenesis by exclusion of TTRAP from the nucleolus and sequestration into cytoplasmic aggregates via TRAF6Integration of clearance mechanisms: the proteasome and autophagy.Lewy bodies.Alpha-synuclein functions in the nucleus to protect against hydroxyurea-induced replication stress in yeast.Anchanling reduces pathology in a lactacystin- induced Parkinson's disease model.Influence of RNA interference on the mitochondrial subcellular localization of alpha-synuclein and on the formation of Lewy body-like inclusions in the cytoplasm of human embryonic kidney 293 cells induced by the overexpression of alpha-synuclein.Oxidants induce alternative splicing of alpha-synuclein: Implications for Parkinson's disease.Proteomics screening of adenosine triphosphate-interacting proteins in the liver of diazinon-treated rats.Plasma Prolidase Activity and Oxidative Stress in Patients with Parkinson's DiseaseAlpha synuclein gene expression profile in the retina of vertebratesSystemic administration of a proteasome inhibitor does not cause nigrostriatal dopamine degeneration.Conditional expression of Parkinson's disease-related mutant α-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1The role of mitochondria in inherited neurodegenerative diseases.Genetics of iron regulation and the possible role of iron in Parkinson's disease.Novel suppressors of alpha-synuclein toxicity identified using yeastThe Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates.Alpha-synuclein and Parkinson's disease: a proteomic view.The roles of the proteasome pathway in signal transduction and neurodegenerative diseases.Pesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1 in Parkinson׳s disease.Clueless, a conserved Drosophila gene required for mitochondrial subcellular localization, interacts genetically with parkin.Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin.Glutamate receptors as therapeutic targets for Parkinson's disease.A network view on Parkinson's disease.Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration.Autophagic pathways and metabolic stress.Development of Parkinson's disease biomarkers.Molecular biomarkers of lung carcinoma.
P2860
Q24298689-E2FD33EB-A63A-4565-94CF-9091069A9013Q24307946-A2BD8933-C3FD-4577-864B-40FB1C9A2272Q24630927-0589A3EF-DBF5-4E01-881A-312191B2E133Q26852462-49D7C3B7-B578-4288-B218-4EA69E1B3791Q27644069-0CBE3D69-32F4-42A5-B0FA-F896D3550668Q28264682-D45C1EBC-4421-4E94-9E27-7912237013B9Q33311344-DE919659-59B7-4AD2-9CB1-23103C2BC97DQ33364337-A2C812F9-EF37-4151-80C0-627305D5E4F2Q33385971-256F18AA-E3D2-422F-A677-DF78D6673BDEQ33470296-C4EE6383-B8DD-47C2-8CC1-6A6AA98AEF18Q33716773-31C45565-1BCC-44F9-9C81-CFA8055138C0Q33802862-F5EA40C2-4EB0-4650-93A6-839EBBB72969Q33823772-5996F094-74AF-4A68-9E36-6DE0882CFF29Q34245014-8B0F9B69-02A3-4C64-BBC5-813FA0049034Q34313770-5EE08962-44D4-426C-A3DA-291F2AF4E055Q34478663-C8A44DD0-6AF8-46EB-A697-8E446E7C471FQ35155985-663B4270-AC55-4A6F-A4D4-D218714EB31FQ35157726-53D20AD3-4E74-48B1-B2F7-2B970285356BQ35160746-E32DEEF4-DD5D-4510-9B0B-7DE9873524FCQ35797475-C1313406-5C97-44D8-B68A-C3C91F5B08BDQ35882937-B3C80AE7-C815-4CED-8B4B-C295637AF434Q35988121-45C205F9-D4B4-4870-BA9E-7307F7230A74Q36050277-3133109B-407D-4335-938B-AF3D9004E623Q36088792-1FF558A5-744D-4892-9AAB-603FAA1F8A26Q36158367-A270631F-9D5D-49C3-9579-1FABBA703586Q36521932-FB768DF6-90DA-42C0-B349-DDDD00C85807Q36815145-E971A1AB-37D0-46AA-ACE8-C3F5917ED74AQ36967979-215F7ABD-CCC1-46A0-B8E9-7281F8DAE6A9Q37003482-AAB4418D-7368-46E8-9FD8-69AD3C6F0596Q37157838-8C1DAEEB-DCBE-4AED-9549-E04FA9B6F30CQ37171851-FC6B0D14-2714-4018-91CA-DDE281F79D3CQ37320854-422B8349-B32C-441A-8981-38444E0540B7Q37331259-8E8C0437-745E-4B5E-BB17-C169ECB3A823Q37418045-1EEA3CB6-A2D9-4FAB-B405-445A404EA4A0Q37585401-641DF389-C449-41C2-87E3-48AEA57BC056Q37655091-9714D5CC-6165-45AA-B95A-66A9F95AA867Q37755118-83422103-55B4-4E42-9FF6-E86707425883Q37804447-3AC833AB-83CB-40B2-9801-1FAFA606EFD3Q37810992-64C8B2AF-2FFF-42AE-9E70-8ADE379C3E96Q37971659-C20DA916-772B-4720-B209-D0402F668C5C
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Ubiquitin-proteasome system and Parkinson's diseases.
@ast
Ubiquitin-proteasome system and Parkinson's diseases.
@en
type
label
Ubiquitin-proteasome system and Parkinson's diseases.
@ast
Ubiquitin-proteasome system and Parkinson's diseases.
@en
prefLabel
Ubiquitin-proteasome system and Parkinson's diseases.
@ast
Ubiquitin-proteasome system and Parkinson's diseases.
@en
P2093
P1476
Ubiquitin-proteasome system and Parkinson's diseases.
@en
P2093
J Timothy Greenamyre
Ranjita Betarbet
Todd B Sherer
P304
P356
10.1016/J.EXPNEUROL.2004.08.021
P407
P478
191 Suppl 1
P577
2005-02-01T00:00:00Z